Related Experiment Videos
Asanguineous reperfusion in a canine model of cardiopulmonary bypass and controlled postischemic work
I M Rebeyka1, G J Wilson, R A Axford-Gatley
1Department of Surgery, Toronto General Hospital, Ontario, Canada.
Insights
Asanguineous cardioplegic solution reperfusion significantly improves myocardial salvage after global ischemia. This crystalloid solution offers better heart protection compared to blood reperfusion alone.
Area of Science:
- Cardiovascular Surgery
- Cardiology
- Experimental Medicine
Background:
- Global ischemia during cardiac surgery can lead to myocardial damage.
- Optimizing reperfusion strategies is crucial for myocardial salvage.
- Standard blood reperfusion may not provide adequate myocardial protection.
Purpose of the Study:
- To test if asanguineous reperfusion with a crystalloid cardioplegic solution improves myocardial salvage after global ischemia.
- To compare the efficacy of a standard crystalloid cardioplegic solution versus blood reperfusion in protecting the heart.
- To evaluate the impact of different reperfusion methods on myocardial injury and function.
Main Methods:
- Four groups of dogs (n=6 each) underwent cardiopulmonary bypass.
- Groups included controls (work only, ischemia only), ischemia with blood reperfusion, and ischemia with crystalloid cardioplegic solution followed by blood reperfusion.
- Morphological, biochemical, and functional analyses were performed post-ischemia and reperfusion.
Main Results:
- Crystalloid cardioplegic solution reperfusion (Group D) resulted in significantly less myocardial necrosis (2.5% +/- 1.1%) compared to blood reperfusion alone (Group C: 11.4% +/- 2.4%; p < 0.001).
- No significant biochemical differences were observed between groups B, C, and D.
- Diastolic compliance deteriorated in Group C, but no significant systolic dysfunction differences were detected.
Conclusions:
- Initial reperfusion with an asanguineous cardioplegic solution provides superior myocardial protection and salvage compared to reperfusion with blood alone.
- Crystalloid cardioplegic solutions represent a valuable tool for enhancing myocardial protection during cardiac procedures involving ischemia.
- Further research may explore optimal cardioplegic solutions and reperfusion protocols for various clinical scenarios.
Abstract:
This study was designed to test the hypothesis that asanguineous reperfusion with a standard crystalloid cardioplegic solution results in improved myocardial salvage after a period of global ischemia. Four groups of 6 dogs each were placed on cardiopulmonary bypass. Control group A (work only) performed two hours of controlled work by contracting against a saline-filled left intraventricular balloon. Control group B (ischemia only) underwent 45 minutes of global normothermic ischemia before simple blood reperfusion while supported on bypass. Groups C and D were subjected to ischemia and reperfusion as in group B, followed by controlled work stress as in group A. Group D, however, received 500 mL of St. Thomas' Hospital solution immediately before blood reperfusion. Morphological analysis showed no significant injury in groups A and B, whereas group C had 11.4% +/- 2.4% necrosis of heart mass versus 2.5% +/- 1.1% in group D (p less than 0.001). Biochemical data from left ventricular biopsies showed no significant differences between groups B, C, and D. Functional analyses showed deterioration of diastolic compliance in group C (p less than 0.05), although a significant difference in systolic functional indexes could not be detected. Myocardial protection and salvage was improved by initial reperfusion with an asanguineous cardioplegic solution versus reperfusion with blood alone.